SUCEF(SUCEF)
SUCEF
No analyst ratings available
No analyst price targets available for SUCEF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $233.73B | $251.78B | $264.47B | $272.48B | $277.66B |
| Low | $230.22B | $245.02B | $258.87B | $266.72B | $271.78B |
| High | $237.20B | $255.76B | $268.53B | $276.66B | $281.92B |
| EBITDA Avg | $55.68B | $59.98B | $63.01B | $64.91B | $66.15B |
| Low | $54.85B | $58.37B | $61.67B | $63.54B | $64.75B |
| High | $56.51B | $60.93B | $63.97B | $65.91B | $67.16B |
| EBIT Avg | $30.70B | $33.07B | $34.74B | $35.79B | $36.47B |
| Low | $30.24B | $32.18B | $34.00B | $35.03B | $35.70B |
| High | $31.16B | $33.59B | $35.27B | $36.34B | $37.03B |
| Net Income Avg | $10.11B | $16.30B | $20.30B | $23.57B | $23.87B |
| Low | $9.83B | $15.85B | $19.75B | $22.92B | $23.21B |
| High | $10.31B | $16.62B | $20.71B | $24.04B | $24.34B |
| EPS Avg | $315.10 | $508.08 | $632.97 | $734.70 | $744.04 |
| Low | $306.43 | $494.10 | $615.55 | $714.49 | $723.57 |
| High | $321.39 | $518.22 | $645.60 | $749.36 | $758.88 |
| Analysts (Rev / EPS) | 6 / 1 | 5 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $57.00B | $61.86B | $61.26B |
| Low | $56.85B | $61.70B | $61.10B |
| High | $57.15B | $62.02B | $61.42B |
| EBITDA Avg | $13.58B | $14.74B | $14.60B |
| Low | $13.54B | $14.70B | $14.56B |
| High | $13.61B | $14.78B | $14.63B |
| EBIT Avg | $7.49B | $8.13B | $8.05B |
| Low | $7.47B | $8.10B | $8.03B |
| High | $7.51B | $8.15B | $8.07B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 2 / — | 1 / — | 1 / — |